391 related articles for article (PubMed ID: 26972532)
1. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
[TBL] [Abstract][Full Text] [Related]
2. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.
Kanoke A; Fujimura M; Niizuma K; Ito A; Sakata H; Sato-Maeda M; Morita-Fujimura Y; Kure S; Tominaga T
Brain Res; 2015 Oct; 1624():497-505. PubMed ID: 26315378
[TBL] [Abstract][Full Text] [Related]
3. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease.
Sonobe S; Fujimura M; Niizuma K; Nishijima Y; Ito A; Shimizu H; Kikuchi A; Arai-Ichinoi N; Kure S; Tominaga T
Brain Res; 2014 Mar; 1552():64-71. PubMed ID: 24440776
[TBL] [Abstract][Full Text] [Related]
4. Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene.
Sonobe S; Fujimura M; Niizuma K; Fujimura T; Furudate S; Nishijima Y; Kure S; Tominaga T
Neuroreport; 2014 Dec; 25(18):1442-6. PubMed ID: 25383461
[TBL] [Abstract][Full Text] [Related]
5. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
Park MG; Shin JH; Lee SW; Park HR; Park KP
J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
[TBL] [Abstract][Full Text] [Related]
6. Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease.
Ito A; Fujimura M; Niizuma K; Kanoke A; Sakata H; Morita-Fujimura Y; Kikuchi A; Kure S; Tominaga T
Brain Res; 2015 Jan; 1594():310-20. PubMed ID: 25446450
[TBL] [Abstract][Full Text] [Related]
7. Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease.
Sato-Maeda M; Fujimura M; Kanoke A; Morita-Fujimura Y; Niizuma K; Tominaga T
Brain Res; 2016 Jan; 1630():50-5. PubMed ID: 26556774
[TBL] [Abstract][Full Text] [Related]
8. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
9. Differing phenotypes of Moyamoya disease in a familial case involving heterozygous c.14429G > A variant in RNF213.
Inoue T; Murakami N; Sakadume S; Kido Y; Kikuchi A; Ichinoi N; Suzuki K; Kure S; Sakuta R
Pediatr Int; 2015 Aug; 57(4):798-801. PubMed ID: 26315205
[TBL] [Abstract][Full Text] [Related]
10. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
[TBL] [Abstract][Full Text] [Related]
11. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
[TBL] [Abstract][Full Text] [Related]
12. A new horizon of moyamoya disease and associated health risks explored through RNF213.
Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
[TBL] [Abstract][Full Text] [Related]
13. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells.
Ohkubo K; Sakai Y; Inoue H; Akamine S; Ishizaki Y; Matsushita Y; Sanefuji M; Torisu H; Ihara K; Sardiello M; Hara T
Sci Rep; 2015 Aug; 5():13191. PubMed ID: 26278786
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of
Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
[No Abstract] [Full Text] [Related]
15. De Novo Development of Moyamoya Disease after Stereotactic Radiosurgery for Brain Arteriovenous Malformation in a Patient With RNF213 p.Arg4810Lys (rs112735431).
Torazawa S; Miyawaki S; Shinya Y; Kawashima M; Hasegawa H; Dofuku S; Uchikawa H; Kin T; Shin M; Nakatomi H; Saito N
World Neurosurg; 2020 Aug; 140():276-282. PubMed ID: 32434013
[TBL] [Abstract][Full Text] [Related]
16. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
[TBL] [Abstract][Full Text] [Related]
17. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
Liao X; Deng J; Dai W; Zhang T; Yan J
Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
[TBL] [Abstract][Full Text] [Related]
18. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
[TBL] [Abstract][Full Text] [Related]
19. Ablation of Rnf213 retards progression of diabetes in the Akita mouse.
Kobayashi H; Yamazaki S; Takashima S; Liu W; Okuda H; Yan J; Fujii Y; Hitomi T; Harada KH; Habu T; Koizumi A
Biochem Biophys Res Commun; 2013 Mar; 432(3):519-25. PubMed ID: 23410753
[TBL] [Abstract][Full Text] [Related]
20. [Precision Medicine for Moyamoya Disease].
Fujimura M
No Shinkei Geka; 2022 Jan; 50(1):216-221. PubMed ID: 35169101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]